Diroximel Fumarate
Diroximel Fumarate

Diroximel Fumarate

Catalog NumberPI1577222140

CAS Number1577222-14-0

CategoryDrugs Influencing Immune Function

Diroximel fumarate, also known as ALKS-8700, is in Phase III clinical trials for the treatment of relapsing remitting multiple sclerosis, which is the most common form of multiple sclerosis (MS). Relapsing remitting MS is characterized by episodes of worsening neurologic functioning followed by partial or complete recovery periods free of disease progression.
Diroximel Fumarate

* Our products are for research use only.

Get in Touch

We're glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

For product and service inquiries icon1

For product and service inquiries, please use our online system or send an email to .

For product and service inquiries icon2